Advamed Payment Alert: Breakthrough Pathway Payment for Medical Devices
August 9, 2019
level to 65 percent.
These changes represent significant wins for coverage and payment of innovative medical devices and are the latest in a series of payment policy victories that are the result of our multi-year advocacy efforts.
Key highlights of the final rule include the following:
- Alternative NTAP Pathway for Breakthrough Devices and QIDPs
- Change to the Calculation of the NTAP Payment Amount
- Clarifications to the Substantial Clinical Improvement Criterion
- New Technology Add-On Payments (NTAPs) Applications
- Antimicrobial Resistance Diagnoses as Complications and Comorbidities
- Payment Rate Update
Read the Press Release/Fact Sheet.
Recent News
- Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
- Owlet Announces Creation of Baby Safety Task Force to Educate, Innovate, and Advocate for Better Baby Safety Standards
- BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
- Freyya Closes Oversubscribed Pre-Seed Financing to Advance FDA Regulatory Milestones, Commercialization
- In Memory of Dr. Michael Rinck, Founder, MT Promedt Consulting GmbH
- bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies
